The abstract is read at the publisher; the summary is JClub's.
A multisite oral–gut microbial signature distinguishes Parkinson’s disease cognitive groups, with MOFA2 Factor 8 showing β = -0.58 (p < 0.0001) across 150 participants.
- Why it matters: Cognitive impairment drives disability in Parkinson’s disease, but the body-wide microbial changes linked to cognitive dysfunction across stages are not well defined.
- What they did: Using 16S rRNA gene sequencing from five body sites (616 samples) in healthy controls, PD-MCI, and PDD, MOFA2 and MintTea modeled cognitive-status–associated microbial modules (PD-MCI vs PDD AUROC = 0.810).
- The result: Core microbiome analysis showed a net loss of 45 genus-site core memberships and reduced Roseburia prevalence in cognitively impaired participants, while cross-site correspondence weakened non-linearly at dementia (Global Body-wide Organization Index: 0.335 HC, 0.341 PD-MCI, 0.257 PDD).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.